1,786
Views
4
CrossRef citations to date
0
Altmetric
Review

Fetal Origins of Autism Spectrum Disorders: the Non-Associated Maternal Factors

, , , &
Article: FSO114 | Accepted 19 Feb 2016, Published online: 21 Mar 2016

References

  • Association AP . Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Association, Washington, DC, USA (2013).
  • Elsabbagh M , DivanG, KohYJet al. Global prevalence of autism and other pervasive developmental disorders. Autism Res.5(3), 160–179 (2012).
  • Kim YS , LeventhalBL, KohYJet al. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry168(9), 904–912 (2011).
  • Stokstad E . Development. New hints into the biological basis of autism. Science294(5540), 34–37 (2001).
  • Mcdonald ME , PaulJF. Timing of increased autistic disorder cumulative incidence. Environ. Sci. Technol.44(6), 2112–2118 (2010).
  • Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, Prevention . Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill. Summ.63(2), 1–21 (2014).
  • Chen JA , PenagarikanoO, BelgardTG, SwarupV, GeschwindDH. The emerging picture of autism spectrum disorder: genetics and pathology. Annu. Rev. Pathol.10, 111–144 (2015).
  • Schaefer GB , MendelsohnNJ. Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet. Med.10(1), 4–12 (2008).
  • Artigas-Pallares J , Gabau-VilaE, Guitart-FeliubadaloM. [Syndromic autism: II. Genetic syndromes associated with autism]. Rev. Neurol.40(Suppl. 1), S151–S162 (2005).
  • Herman GE , HenningerN, Ratliff-SchaubK, PastoreM, FitzgeraldS, McBrideKL. Genetic testing in autism: how much is enough?Genet. Med.9(5), 268–274 (2007).
  • Schaefer GB , LutzRE. Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet. Med.8(9), 549–556 (2006).
  • Connors SL , LevittP, MatthewsSGet al. Fetal mechanisms in neurodevelopmental disorders. Pediatr. Neurol.38(3), 163–176 (2008).
  • Blaxill MF , RedwoodL, BernardS. Thimerosal and autism? A plausible hypothesis that should not be dismissed. Med. Hypotheses62(5), 788–794 (2004).
  • Stehr-Green P , TullP, StellfeldM, MortensonPB, SimpsonD. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am. J. Prev. Med.25(2), 101–106 (2003).
  • Fombonne E , ZakarianR, BennettA, MengL, Mclean-HeywoodD. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics118(1), e139–e150 (2006).
  • Pichichero ME , CernichiariE, LopreiatoJ, TreanorJ. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet360(9347), 1737–1741 (2002).
  • Madsen KM , LauritsenMB, PedersenCBet al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics112(3 Pt 1), 604–606 (2003).
  • Taylor B , MillerE, FarringtonCPet al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet353(9169), 2026–2029 (1999).
  • Madsen KM , HviidA, VestergaardMet al. A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med.347(19), 1477–1482 (2002).
  • Szklo M . Population-based cohort studies. Epidemiol. Rev.20(1), 81–90 (1998).
  • Hertz-Picciotto I , CroenLA, HansenR, JonesCR, Van De WaterJ, PessahIN. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ. Health Perspect.114(7), 1119–1125 (2006).
  • Ludvigsson JF , Otterblad-OlaussonP, PetterssonBU, EkbomA. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur. J. Epidemiol.24(11), 659–667 (2009).
  • Lee BK , MagnussonC, GardnerRMet al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain. Behav. Immun.44, 100–105 (2015).
  • Ludvigsson JF , ReichenbergA, HultmanCM, MurrayJA. A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders. JAMA Psychiatry70(11), 1224–1230 (2013).
  • Krakowiak P , WalkerCK, BremerAAet al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics129(5), e1121–e1128 (2012).
  • Zerbo O , IosifAM, WalkerC, OzonoffS, HansenRL, Hertz-PicciottoI. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J. Autism Dev. Disord.43(1), 25–33 (2013).
  • Lyall K , AshwoodP, Van De WaterJ, Hertz-PicciottoI. Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J. Autism Dev. Disord.44(7), 1546–1555 (2014).
  • Lyall K , PaulsDL, SpiegelmanD, AscherioA, SantangeloSL. Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses’ Health Study II. Autism Res.5(1), 21–30 (2012).
  • Buchmayer S , JohanssonS, JohanssonA, HultmanCM, SparenP, CnattingiusS. Can association between preterm birth and autism be explained by maternal or neonatal morbidity?Pediatrics124(5), e817–e825 (2009).
  • Gunnes N , SurenP, BresnahanMet al. Interpregnancy interval and risk of autistic disorder. Epidemiology24(6), 906–912 (2013).
  • American College Of O, Gynecologists, Task Force on Hypertension In P. Hypertension in pregnancy . Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet. Gynecol.122(5), 1122–1131 (2013).
  • Germain SJ , SacksGP, SoorannaSR, SargentIL, RedmanCW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol.178(9), 5949–5956 (2007).
  • Mutter WP , KarumanchiSA. Molecular mechanisms of preeclampsia. Microvasc. Res.75(1), 1–8 (2008).
  • Lavelle TA , WeinsteinMC, NewhouseJP, MunirK, KuhlthauKA, ProsserLA. Economic burden of childhood autism spectrum disorders. Pediatrics133(3), e520–e529 (2014).
  • Shimabukuro TT , GrosseSD, RiceC. Medical expenditures for children with an autism spectrum disorder in a privately insured population. J. Autism Dev. Disord.38(3), 546–552 (2008).